Multiple Myeloma

Showing NaN - NaN of 67

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multiple Myeloma Trial in Germany, Greece (Daratumumab, Bortezomib, Dexamethasone)

Completed
  • Multiple Myeloma
  • Berlin, Germany
  • +9 more
May 27, 2022

Multiple Myeloma, Plasma Cell Disorder Trial in Germany, United States (HDP-101)

Recruiting
  • Multiple Myeloma
  • Plasma Cell Disorder
  • Atlanta, Georgia
  • +5 more
Mar 10, 2022

Multiple Myeloma Trial in Worldwide (Daratumumab, Bortezomib, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • Adelaide, Australia
  • +51 more
Feb 16, 2022

Presentation, Treatment Patterns, and Outcomes in Multiple

Completed
  • Multiple Myeloma
  • No Intervention
  • Little Rock, Arkansas
  • +136 more
Feb 15, 2022

Multiple Myeloma Trial in Worldwide (PDR001, CJM112, LCL161)

Completed
  • Multiple Myeloma
  • Phoenix, Arizona
  • +7 more
Feb 7, 2022

Multiple Myeloma Trial in Worldwide (Elotuzumab, Dexamethasone, Lenalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Tucson, Arizona
  • +37 more
Jan 14, 2022

Multiple Myeloma Trial in Germany (Lenalidomide, Bortezomib, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Aachen, Germany
  • +72 more
Jan 12, 2022

Multiple Myeloma Trial in Worldwide (Elotuzumab, Pomalidomide, Dexamethasone)

Completed
  • Multiple Myeloma
  • Atlanta, Georgia
  • +54 more
Jan 11, 2022

Multiple Myeloma Trial in Austria, Germany (MOR03087 phase 1 dose escalation, MOR03087, Dexamethasone)

Completed
  • Multiple Myeloma
  • MOR03087 phase 1 dose escalation
  • +4 more
  • Vienna, Austria
  • +9 more
Nov 12, 2021

Relapsed or Refractory Haematological Malignancies Including, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in

Completed
  • Relapsed or Refractory Haematological Malignancies Including
  • +10 more
  • Aachen, Germany
  • +11 more
Oct 21, 2021

Multiple Myeloma Trial in Worldwide (HLA Matched allogeneic transplant)

Completed
  • Multiple Myeloma
  • HLA Matched allogeneic transplant
  • Wien, Austria
  • +23 more
Oct 5, 2021

Multiple Myeloma Trial in Germany (elotuzumab, Lenalidomide, Bortezomib)

Completed
  • Multiple Myeloma
  • Aschaffenburg, Germany
  • +67 more
Sep 9, 2021

Multiple Myeloma Trial in Hamburg, Heidelberg, Mainz (Cyclophosphamide)

Active, not recruiting
  • Multiple Myeloma
  • Hamburg, Germany
  • +2 more
Aug 20, 2021

Multiple Myeloma Trial in Worldwide (Cobimetinib, Venetoclax, Atezolizumab)

Completed
  • Multiple Myeloma
  • Brno, Czechia
  • +27 more
Aug 5, 2021

Multiple Myeloma Trial in Worldwide (Durvalumab, Pomalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Little Rock, Arkansas
  • +34 more
Aug 4, 2021

Multiple Myeloma Trial in Germany, United States (LBH589)

Terminated
  • Multiple Myeloma
  • Scottsdale, Arizona
  • +28 more
Jun 22, 2021

Multiple Myeloma Trial in Worldwide (LGH447, midazolam)

Completed
  • Multiple Myeloma
  • Chicago, Illinois
  • +7 more
Dec 16, 2020

Multiple Myeloma Trial in Germany (Bendamustine, Bortezomib, Prednisone)

Completed
  • Multiple Myeloma
  • Bendamustine, Bortezomib, Prednisone
  • Mannheim, Ba-Wü, Germany
  • +14 more
Oct 14, 2020

Multiple Myeloma Trial in Worldwide (Panobinostat)

No longer available
  • Multiple Myeloma
  • Innsbruck, Tyrol, Austria
  • +39 more
Apr 6, 2020

Multiple Myeloma Trial in Worldwide (pomalidomide)

Completed
  • Multiple Myeloma
  • Adelaide, Australia
  • +90 more
Nov 7, 2019

Multiple Myeloma Trial in Worldwide (Thalidomide, Dexamethasone)

Completed
  • Multiple Myeloma
  • Pleven, Bulgaria
  • +85 more
Nov 14, 2019

Multiple Myeloma Trial in Worldwide (Placebo, Dexamethasone, Bortezomib)

Completed
  • Multiple Myeloma
  • Placebo
  • +3 more
  • Tucson, Arizona
  • +56 more
Sep 25, 2019

Multiple Myeloma Trial in Worldwide (venetoclax, lenalidomide, dexamethasone)

Withdrawn
  • Multiple Myeloma
  • Duarte, California
  • +21 more
Aug 23, 2019

Multiple Myeloma Trial in Worldwide (Cyclophosphamide, Ixazomib, Dexamethasone)

Completed
  • Multiple Myeloma
  • Hazard, Kentucky
  • +23 more
Jun 24, 2019